QA108 Phase III Study in Subjects With Intermediate AMD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

QA108 Phase III Study in Subjects With Intermediate AMD — Stella

Recruiting

Back to Intermediate Age-Related Macular Degeneration trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Beijing Hospital, Beijing

Key details

Phase

Large-scale testing

Sponsor

Smilebiotek Zhuhai Limited

Enrollment target

~400 participants

Started

July 2025

Primary completion

March 2027

Age range

45 Years – 85 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov